4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001966716-26-000010
GENERAL COUNSEL & CORP SEC sold 1,457 shares at $29.95 ($43,637)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Allan Jonathan · GENERAL COUNSEL & CORP SEC
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-16 | Sale : show line 1 in the form 10b5-1 | −1,457 | $29.95 | $43,637 | 18,086 | D |
| Open-market sales · 1,457 sh · avg $29.95 · $43,637 | ||||||
Loading xslF345X06/form4-06182026_080652.xml…